Treatment of Severe Pain and Opioid-induced Constipation: An Observational Study of Quality of Life, Resource Use, and Costs in Sweden

Chronic Pain

Long-term use of naldemedine in the treatment of opioid-induced constipation in patients with chronic non-cancer pain: a randomized, double-blind, placebo-controlled phase 3 study

Pain.

Webster LR, Nalamachu S, Morlion B, Reddy J, Baba Y, Yamada T, Arjona Ferreira JC

doi: 10.1097/

Cancer PainNeuropathic Pain

Multiple effectiveness aspects of tapentadol for moderate-severe cancer-pain treatment: an observational prospective study

J Pain Res.

Cascella M, Forte CA, Bimonte S, Esposito G, Romano C, Costanzo R, Morabito A, Cuomo A

doi: 10.2147/JPR.S181079.

Pain Management

The Burden of Opioid-Induced Constipation in Younger Patients with Chronic Noncancer Pain

Pain Med.

Gupta A, Coyne KS, Datto C, Venuti C

doi: 10.1093/pm/pny002.

Chronic Pain

The role of oxycodone/naloxone in the management of patients with pain and opioid-induced constipation

Expert Opin Pharmacother.

Leppert W, Zajaczkowska R, Wordliczek J

doi: 10.1080/14656566.

Cancer Pain

Careful Breakthrough Cancer Pain Treatment through Rapid-Onset Transmucosal Fentanyl Improves the Quality of Life in Cancer Patients: Results from the BEST Multicenter Study

J Clin Med.

Cuomo A, Cascella M, Forte CA, Bimonte S, Esposito G, De Santis S, Cavanna L, Fusco F, Dauri M, Natoli S, Maltoni M, Morabito A, Mediati RD, Lorusso V, Barni S, Porzio G, Mercadante S, Crispo A

doi: 10.3390/jcm9041003.

Acute PainChronic Pain

Peripheral Opioid Receptor Antagonists for Opioid-Induced Constipation: A Primer on Pharmacokinetic Variabilities with a Focus on Drug Interactions

J Pain Res.

Gudin J, Fudin J

doi: 10.2147/JPR.S220859.

Back Pain

Oral methylnaltrexone does not negatively impact analgesia in patients with opioid-induced constipation and chronic noncancer pain

J Pain Res.

Webster LR, Israel RJ

doi: 10.2147/JPR.S160488.

COMMENTED

Chronic Pain

Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study

Lancet Public Health.

Campbell G, Hall WD, Peacock A, Lintzeris N, Bruno R, Larance B, Nielsen S, Cohen M, Chan G, Mattick RP, Blyth F, Shanahan M, Dobbins T, Farrell M, Degenhardt L

doi: 10.1016/S2468-2667

RECOMMENDED

Chronic Pain

No increased pain among opioid-dependent individuals treated with extended-release naltrexone or buprenorphine-naloxone: A 3-month randomized study and 9-month open-treatment follow-up study

Am J Addict.

Latif ZE, Solli KK, Opheim A, Kunoe N, Benth JŠ, Krajci P, Sharma-Haase K, Tanum L

doi: 10.1111/ajad.12859.

Related content

Long-term use of naldemedine in the treatment of opioid-induced constipation in patients with chronic non-cancer pain: a randomized, double-blind, placebo-controlled phase 3 study

Multiple effectiveness aspects of tapentadol for moderate-severe cancer-pain treatment: an observational prospective study

The Burden of Opioid-Induced Constipation in Younger Patients with Chronic Noncancer Pain

The role of oxycodone/naloxone in the management of patients with pain and opioid-induced constipation

Careful Breakthrough Cancer Pain Treatment through Rapid-Onset Transmucosal Fentanyl Improves the Quality of Life in Cancer Patients: Results from the BEST Multicenter Study

Peripheral Opioid Receptor Antagonists for Opioid-Induced Constipation: A Primer on Pharmacokinetic Variabilities with a Focus on Drug Interactions

Oral methylnaltrexone does not negatively impact analgesia in patients with opioid-induced constipation and chronic noncancer pain

Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study

No increased pain among opioid-dependent individuals treated with extended-release naltrexone or buprenorphine-naloxone: A 3-month randomized study and 9-month open-treatment follow-up study